Norges Bank’s aTyr Pharma ATYR Stock Holding History

Norges Bank’s Portfolio ATYR Stock Details ATYR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-714	Closed	-$185K	–	2330
2015 Q2	$185K	Buy	+714	New	+$222K	﹤0.01%	2232

Other funds holding ATYR

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

PVMCV

Polaris Venture Management Co V Boston, Massachusetts $14.1M AUM 121.41% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

RIM

RS Investment Management San Francisco, California $9.73B AUM 3.24% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

TAM

Tiverton Asset Management Wilimington, Delaware $2.88B AUM 5.6% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

RCM

Riverhead Capital Management Wilmington, Delaware $2.71B AUM 2.34% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Norges Bank's ATYR Position: Q3 2015 in Review

Norges Bank sold out of aTyr Pharma (ATYR) in Q3 2015, closing a stake of 714 shares — an estimated $185K sold.

Norges Bank first reported a position in ATYR in Q2 2015 and held it in 1 quarter. The position peaked at $185K in Q2 2015. 50 funds tracked by Wall St. Rank hold ATYR as of Q3 2015.

Norges Bank reported no remaining aTyr Pharma position as of Q3 2015 after selling out during the quarter.
Norges Bank sold 714 aTyr Pharma shares in Q3 2015, an estimated $185K.
Norges Bank first reported a position in aTyr Pharma in Q2 2015 and held it in 1 quarter.
Norges Bank's aTyr Pharma position peaked at $185K in Q2 2015.
50 funds tracked by Wall St. Rank held aTyr Pharma as of Q3 2015.

Based on Norges Bank's 13F filing for Q3 2015, filed 6 Nov 2015.